Monika Gullerova, Professor of Molecular Medicine and our Tutor in Medicine, is one of six Oxford University researchers selected among twelve finalists for the 2025–2027 MIT-Royalty Pharma Prize Competition to support entrepreneurs in biotech.
The University of Oxford and MIT have joined forces to bridge the worlds of academia and entrepreneurship through the MIT-Royalty Pharma Faculty Founder Prize Competition. This two-year initiative (October 2025 – May 2027) empowers faculty at both institutions to translate human health technologies - including diagnostics, therapeutics, devices, and AI‑driven digital health into real-world impact. The 12 finalists for its third prize competition include six each from MIT and from the University of Oxford. The initiative, recently renamed in recognition of a gift by Royalty Pharma, runs a two-year programme that supports biotech innovators and faculty entrepreneurs interested in commercialising their solutions.
Many congratulations to Professor Gullerova and her fellow finalists.
Professor Monika Gullerova (third from right, back row) with fellow finalists.
The NIHR Applied Research Collaboration Thames Valley, co-led by our Senior Research Fellow, Kam Bhui, will work with healthcare professionals and the public to find solutions to local health needs.
